Cargando…
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836835/ https://www.ncbi.nlm.nih.gov/pubmed/33521659 http://dx.doi.org/10.1016/S2665-9913(20)30270-8 |
| _version_ | 1783642830800945152 |
|---|---|
| author | Mehta, Puja Porter, Joanna C Chambers, Rachel C Isenberg, David A Reddy, Venkat |
| author_facet | Mehta, Puja Porter, Joanna C Chambers, Rachel C Isenberg, David A Reddy, Venkat |
| author_sort | Mehta, Puja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7836835 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78368352021-01-26 B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? Mehta, Puja Porter, Joanna C Chambers, Rachel C Isenberg, David A Reddy, Venkat Lancet Rheumatol Correspondence Elsevier Ltd. 2020-10 2020-07-31 /pmc/articles/PMC7836835/ /pubmed/33521659 http://dx.doi.org/10.1016/S2665-9913(20)30270-8 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Mehta, Puja Porter, Joanna C Chambers, Rachel C Isenberg, David A Reddy, Venkat B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title | B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title_full | B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title_fullStr | B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title_full_unstemmed | B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title_short | B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? |
| title_sort | b-cell depletion with rituximab in the covid-19 pandemic: where do we stand? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836835/ https://www.ncbi.nlm.nih.gov/pubmed/33521659 http://dx.doi.org/10.1016/S2665-9913(20)30270-8 |
| work_keys_str_mv | AT mehtapuja bcelldepletionwithrituximabinthecovid19pandemicwheredowestand AT porterjoannac bcelldepletionwithrituximabinthecovid19pandemicwheredowestand AT chambersrachelc bcelldepletionwithrituximabinthecovid19pandemicwheredowestand AT isenbergdavida bcelldepletionwithrituximabinthecovid19pandemicwheredowestand AT reddyvenkat bcelldepletionwithrituximabinthecovid19pandemicwheredowestand |